1.
King TE Jr, Lee JS. Cryptogenic organizing pneumonia. N Engl J Med. 2022;386(11):1058-1069.
2.
Choi KH, Lee HB, Jeong MY, et al. The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia. Chest. 2002;121(5):1478-1485.
3.
Lappi-Blanco E, Soini Y, Kinnula V, et al. VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia. J Pathol. 2002;196(2):220-227.
4.
Gaillet G, Favelle O, Guilleminault L, et al. Gastroesophageal reflux disease is a risk factor for severity of organizing pneumonia. Respiration. 2015;89(2):119-126.
5.
Zhang Y, Li N, Li Q, et al. Analysis of the clinical characteristics of 176 patients with pathologically confirmed cryptogenic organizing pneumonia. Ann Transl Med. 2020;8(12):763.
6.
Ozdemirel TS, Bulut S, Akkurt ES, et al. Does cryptogenic organizing pneumonia change seasonal? Rev Assoc Med Bras (1992). 2023;69(2):267-271.
7.
Izumi T, Kitaichi M, Nishimura K, Nagai S. Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis. Chest. 1992;102(3):715-719.
8.
Bartter T, Irwin RS, Nash G, et al. Idiopathic bronchiolitis obliterans organizing pneumonia with peripheral infiltrates on chest roentgenogram. Arch Intern Med. 1989;149(2):273-279.
9.
Cordier JF. Organising pneumonia. Thorax. 2000; 55(4):318-328.
10.
Cordier JF. Cryptogenic organising pneumonia. Eur Respir J. 2006;28(2): 422-446.
11.
Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008; 63(Suppl 5):v1-58.
12.
Niksarlıoğlu EY, Özkan GZ, Bakan ND, Yurt S, Kılıç L, Çamsarı G. Cryptogenic organizing pneumonia: clinical and radiological features, treatment outcomes of 17 patients, and review of the literature. Turk J Med Sci. 2016;46(6):1712-1718.
13.
Stover DE, Mangino D. Macrolides: a treatment alternative for bronchiolitis obliterans organizing pneumonia? Chest. 2005;128(5):3611-3617.
14.
Vaz AP, Morais A, Melo N, et al. Azithromycin as an adjuvant therapy in cryptogenic organizing pneumonia. Rev Port Pneumol. 2011;17(4):186-189.
15.
Lazor R, Vandevenne A, Pelletier A, et al. Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles "Orphelines" Pulmonaires (GERM"O"P). Am J Respir Crit Care Med. 2000;162(2 Pt 1): 571-577.
16.
Kim M, Cha SI, Seo H, et al. Predictors of relapse in patients with organizing pneumonia. Tuberc Respir Dis (Seoul). 2015;78(3):190-195.
17.
Saito Z, Kaneko Y, Hasegawa T, et al. Predictive factors for relapse of cryptogenic organizing pneumonia. BMC Pulm Med. 2019;9;19(1):10.